Loading...
Stepan Co (SCL) does not present a compelling buy opportunity at this time for a beginner investor with a long-term strategy. While the stock is oversold based on RSI and has a positive analyst upgrade, the weak financial performance in Q4 2025, negative MACD, and lack of strong trading signals suggest waiting for a clearer upward trend before investing.
The stock is currently oversold with an RSI of 19.209, indicating potential for a rebound. However, the MACD is negatively expanding at -2.161, suggesting bearish momentum. Moving averages are converging, and the price is near the S1 support level of 52.149, with a pre-market price of 51.33.

Analyst upgrade to 'Buy' with a $75 price target by Seaport Research.
Dividend increase to $0.395 per share, reflecting shareholder commitment.
Revenue and net income growth YoY in Q4 2025.
Q4 2025 non-GAAP EPS loss of -$0.02, missing expectations.
Gross margin dropped by -13.81% YoY.
MACD and technical indicators suggest bearish momentum.
No significant hedge fund or insider trading activity.
In Q4 2025, revenue grew by 5.38% YoY to $553.89 million, and net income increased by 49.37% YoY to $5 million. However, gross margin dropped by -13.81% YoY, and the company reported a non-GAAP EPS loss of -$0.02, missing expectations.
Seaport Research upgraded Stepan Co to 'Buy' from 'Neutral' with a $75 price target, citing potential for recovery despite sluggish demand in the chemical sector.